| Title : Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease - Cummings_2001_J.Geriatr.Psychiatry.Neurol_14_101 |
| Author(s) : Cummings JL , Nadel A , Masterman D , Cyrus PA |
| Ref : J Geriatr Psychiatry Neurol , 14 :101 , 2001 |
| Abstract : |
| PubMedSearch : Cummings_2001_J.Geriatr.Psychiatry.Neurol_14_101 |
| PubMedID: 11419566 |
| Title : Randomized, double-blind, placebo-controlled, multicenter study to evaluate the safety and tolerability of metrifonate in patients with probable Alzheimer disease. The Metrifonate Study Group - Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39 |
| Author(s) : Blass JP , Cyrus PA , Bieber F , Gulanski B |
| Ref : Alzheimer Disease & Associated Disorders , 14 :39 , 2000 |
| Abstract : |
| PubMedSearch : Blass_2000_Alzheimer.Dis.Assoc.Disord_14_39 |
| PubMedID: 10718203 |
| Title : Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials - Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| Author(s) : Farlow MR , Cyrus PA |
| Ref : Dementia & Geriatric Cognitive Disorders , 11 :202 , 2000 |
| Abstract : |
| PubMedSearch : Farlow_2000_Dement.Geriatr.Cogn.Disord_11_202 |
| PubMedID: 10867446 |
| Title : Metrifonate enhances the ability of Alzheimer's disease patients to initiate, organize, and execute instrumental and basic activities of daily living - Gelinas_2000_J.Geriatr.Psychiatry.Neurol_13_9 |
| Author(s) : Gelinas I , Gauthier S , Cyrus PA |
| Ref : J Geriatr Psychiatry Neurol , 13 :9 , 2000 |
| Abstract : |
| PubMedSearch : Gelinas_2000_J.Geriatr.Psychiatry.Neurol_13_9 |
| PubMedID: 10753002 |
| Title : Metrifonate treatment of AD: influence of APOE genotype - Farlow_1999_Neurology_53_2010 |
| Author(s) : Farlow MR , Cyrus PA , Nadel A , Lahiri DK , Brashear A , Gulanski B |
| Ref : Neurology , 53 :2010 , 1999 |
| Abstract : |
| PubMedSearch : Farlow_1999_Neurology_53_2010 |
| PubMedID: 10599773 |
| Title : The effects of metrifonate on the cognitive, behavioral, and functional performance of Alzheimer's disease patients. Metrifonate Study Group - Raskind_1999_J.Clin.Psychiatry_60_318 |
| Author(s) : Raskind MA , Cyrus PA , Ruzicka BB , Gulanski BI |
| Ref : J Clin Psychiatry , 60 :318 , 1999 |
| Abstract : |
| PubMedSearch : Raskind_1999_J.Clin.Psychiatry_60_318 |
| PubMedID: 10362441 |
| Title : Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group [see comments] [published erratum appears in Neurology 1998 Jul\;51(1):332] - Cummings_1998_Neurology_50_1214 |
| Author(s) : Cummings JL , Cyrus PA , Bieber F , Mas J , Orazem J , Gulanski B |
| Ref : Neurology , 50 :1214 , 1998 |
| Abstract : |
| PubMedSearch : Cummings_1998_Neurology_50_1214 |
| PubMedID: 9595966 |
| Title : Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease [see comments] - Morris_1998_Neurology_50_1222 |
| Author(s) : Morris JC , Cyrus PA , Orazem J , Mas J , Bieber F , Ruzicka BB , Gulanski B |
| Ref : Neurology , 50 :1222 , 1998 |
| Abstract : |
| PubMedSearch : Morris_1998_Neurology_50_1222 |
| PubMedID: 9595967 |